SDM

structure given in first source; composed of 2 9-aminoacridines linked via the amino groups by a spermine side chain & via the 4-positions by a N,N'-((methylthio)ethyl)succinamide side chain

Networked: 202 relevant articles (10 outcomes, 34 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Légaré, France: 8 articles (07/2015 - 01/2010)
2.	Hirose, Masao: 8 articles (06/2012 - 03/2004)
3.	Stacey, Dawn: 5 articles (07/2015 - 01/2010)
4.	Imai, Toshio: 5 articles (06/2012 - 03/2004)
5.	Schroy, Paul C: 4 articles (10/2015 - 01/2011)
6.	Labrecque, Michel: 4 articles (01/2013 - 01/2011)
7.	Nishikawa, Akiyoshi: 4 articles (06/2012 - 10/2009)
8.	Hasumura, Mai: 4 articles (06/2012 - 03/2004)
9.	Heeren, Timothy C: 3 articles (10/2015 - 01/2011)
10.	Vleggeert-Lankamp, Carmen L A: 3 articles (01/2014 - 01/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2013 - "Thus healthcare professionals and parents need to know how they should involve children in decision-making and what interventions are most effective in promoting shared decision-making (SDM) for children with cancer. " 10/02/2015 - "We conducted a trial of SDM training for physicians who treat patients with cancer. " 01/01/2013 - "Randomised controlled trials (RCTs) of SDM interventions for children with cancer aged four to 18 years. " 11/01/2015 - "The review found weak, but suggestive, evidence for a positive association between perceived patient involvement in decision making, a central dimension of SDM, and QOL outcomes in cancer. " 11/01/2015 - "This review systematically examines the association between treatment SDM and QOL outcomes in cancer. "
2.	Macular Edema 01/01/2011 - "Eight eyes of 8 diabetic patients with clinically significant macular edema were treated with SDM. " 01/01/2014 - "The purpose of this study was to evaluate subthreshold diode-laser micropulse (SDM) photocoagulation as a primary and secondary line of treatment for clinically significant diabetic macular edema (CSDME). " 01/01/2011 - "Short duration SDM for diabetic macular edema has no significant effect on retinal sensitivity." 11/01/2011 - "Forty-six eyes of 33 patients with clinically significant macular edema (CSME) caused by diabetic retinopathy were randomized to either SDM (810?nm) laser or the conventional double-frequency Nd:YAG (532?nm) laser. " 11/01/2011 - "SDM laser photocoagulation showed an equally good effect on visual acuity, contrast sensitivity, and reduction of diabetic macular edema (DME) as compared to conventional Nd:YAG laser photocoagulation. "
3.	Diabetic Retinopathy (Retinopathy, Diabetic) 02/01/2012 - "Mean BCVA improved more than 6 early treatment of diabetic retinopathy study letters in the SDM, decreased by one letter in the BCZ, and by two letters in the control group. " 05/01/2008 - "To report the visual acuity and clinical outcomes of a pilot study of subthreshold diode micropulse (SDM) panretinal photocoagulation (PRP) for treatment of diabetic retinopathy. " 01/01/2005 - "The results of infrared (810 nm) SDM laser photocoagulation for CSMO were retrospectively reviewed in 95 eyes of 69 consecutive patients with mild to moderate non-proliferative diabetic retinopathy. " 11/01/2011 - "Forty-six eyes of 33 patients with clinically significant macular edema (CSME) caused by diabetic retinopathy were randomized to either SDM (810?nm) laser or the conventional double-frequency Nd:YAG (532?nm) laser. " 05/01/2008 - "Further study of the safety, efficacy, and optimal treatment parameters of SDM pan retinal photocoagulation for diabetic retinopathy is warranted."
4.	Chronic Disease (Chronic Diseases) 04/01/2015 - "SDM has been associated with improved outcomes among patients with various chronic disease states. " 01/01/2015 - "Our objective in the present study is to pilot an IP-SDM and goal-setting toolkit following the Knowledge-to-Action Framework to assess (1) intervention fidelity and the feasibility of conducting a larger trial and (2) impact on decisional conflict, diabetes distress, health-related quality of life and patient assessment of chronic illness care. " 09/01/2015 - "Based on the results of this review, the authors suggest assessing the impact of SDM within the context of chronic disease management where multiple therapeutic options exist, and outcomes may be measured long-term." 01/01/2014 - "To systematically develop and test an interprofessional SDM and goal-setting toolkit for patients with diabetes and other chronic diseases, following the Knowledge to Action framework. " 01/01/2013 - "Shared decision making (SDM) and patient self-management support are key components of US and UK policy for chronic disease management, whereby SDM is seen as enhancing physician-patient negotiation around self-management. "
5.	Dementia (Dementias) 04/01/2014 - "The decision-support intervention piloted in this study was feasible and relevant for surrogate decision-makers of persons with advanced dementia in NHs, and it improved quality of communication between SDM and NH providers. "

Related Drugs and Biologics

1.	Retinaldehyde (Retinal)
2.	Neodymium
3.	Sulfadimethoxine
4.	ormetoprim
5.	Indocyanine Green (Cardio-Green)
6.	Anti-Bacterial Agents (Antibiotics)
7.	Paraffin
8.	Formaldehyde (Formol)
9.	diisopropanolnitrosamine
10.	Insulin (Novolin)

Related Therapies and Procedures

1.	Lasers (Laser)
2.	Light Coagulation
3.	Semiconductor Lasers
4.	Solid-State Lasers
5.	Phototherapy (Light Therapy)